文献速递多重用药衰弱、肌少症与跌倒老年慢病共病管理

住院可作为老年患者出院至养老机构时的处方精简分诊点

Hospital admission as a deprescribing triage point for patients discharged to Residential Aged Care Facilities.
PubMed 文献 · Age Ageing · 2021-01-01

本研究纳入170例急性住院、出院至养老机构、≥75岁且规律用药≥5种的老年患者,评估关键药物类别的处方精简资格与实际发生率,并分析继续使用这些药物对死亡/再入院的联合终点影响。结果显示超多重用药常见(49.4%),质子泵抑制剂(PPI)使用普遍(56%)且89.5%无明确指征,出院时继续使用PPI与1年死亡/再入院风险增加相关(HR 1.54,95%CI 1.06-2.26,P=0.025),主要由再入院驱动。

要点

  • 住院老年患者超多重用药常见,处方精简空间大。
  • PPI使用普遍且多数无明确指征,出院继续使用与再入院风险增加相关。
  • 急性住院可作为处方精简的分诊点,尤其应关注PPI。

核心结论

  • 急性住院是老年患者处方精简的重要分诊点,尤其应针对PPI进行精简。

研究设计与样本

  • 研究纳入170例急性住院、出院至养老机构、≥75岁且规律用药≥5种的老年患者,评估处方精简资格与实际发生率,并分析继续使用指定药物类别对死亡/再入院联合终点的影响。

主要发现

  • 入院时超多重用药(>10种规律药物)常见,占49.4%。
  • 住院期间指定药物类别的处方精简发生率为8-53%,进一步精简潜力为34-90%。
  • PPI使用普遍(56%),其中89.5%无明确指征。
  • 出院时继续使用PPI与1年死亡/再入院风险增加相关(HR 1.54,95%CI 1.06-2.26,P=0.025),主要由再入院驱动。

临床怎么用

  • 对住院老年患者应主动评估处方精简机会,尤其关注PPI的指征与继续使用风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Deprescribing may benefit older frail patients experiencing polypharmacy. We investigated the scope for deprescribing in acutely hospitalised patients and the long-term implications of continuation of medications that could potentially be deprescribed. METHODS: Acutely hospitalised patients (n = 170) discharged to Residential Aged Care Facilities, ≥75 years and receiving ≥5 regular medications were assessed during admission to determine eligibility for deprescribing of key drug classes, along with the actual incidence of deprescribing. The impact of continuation of nominated drug classes (anticoagulants, antidiabetics, antiplatelets, antipsychotics, benzodiazepines, proton pump inhibitors (PPIs), statins) on a combined endpoint (death/readmission) was determined. RESULTS: Hyperpolypharmacy (>10 regular medications) was common (49.4%) at admission. Varying rates of deprescribing occurred during hospitalisation for the nominated drug classes (8-53%), with considerable potential for further deprescribing (34-90%). PPI use was prevalent (56%) and 89.5% of these had no clear indication. Of the drug classes studied, only continued PPI use at discharge was associated with increased mortality/readmission at 1 year (hazard ratio 1.54, 95% confidence interval (1.06-2.26), P = 0.025), driven largely by readmission. CONCLUSION: There is considerable scope for acute hospitalisation to act as a triage point for deprescribing in older patients. PPIs in particular appeared overprescribed in this susceptible patient group, and this was associated with earlier readmission. Polypharmacy in older hospitalised patients should be targeted for possible deprescribing during hospitalisation, especially PPIs.

来源:Age Ageing,查看原文。版权归原作者所有。

引用

  1. Roberts G, Pegoli M, Grzeskowiak L, et al. Hospital admission as a deprescribing triage point for patients discharged to Residential Aged Care Facilities. Age Ageing. 2021. PMID: 34036308. doi:10.1093/ageing/afab082

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。